Articles with public access mandates - Carolyn HoLearn more
Not available anywhere: 6
Review
Genetic testing and counseling for hypertrophic cardiomyopathy
AL Cirino, CE Seidman, CY Ho
Cardiology clinics 37 (1), 35-43, 2019
Mandates: US National Institutes of Health
Review
Screening children at risk for hypertrophic cardiomyopathy: balancing benefits and harms
C Semsarian, CY Ho
European heart journal 40 (45), 3682-3684, 2019
Mandates: National Health and Medical Research Council, Australia
Review
Protein biomarkers of adverse clinical features and events in sarcomeric hypertrophic cardiomyopathy
UA Tahir, P Kolm, RY Kwong, MY Desai, SF Dolman, S Deng, ...
Circulation: Heart Failure 17 (12), e011707, 2024
Mandates: National Institute for Health Research, UK
Review
Demographic-based personalized left ventricular hypertrophy thresholds for hypertrophic cardiomyopathy diagnosis
H Shiwani, RH Davies, CC Topriceanu, R Ditaranto, A Owens, B Raman, ...
Journal of the American College of Cardiology, 2025
Mandates: UK Medical Research Council
Review
The clinical trajectory of NYHA functional class I patients with obstructive hypertrophic cardiomyopathy
M Ahluwalia, J Liu, I Olivotto, V Parikh, EA Ashley, M Michels, J Ingles, ...
JACC: Heart Failure, 2024
Mandates: UK Medical Research Council, Jules Thorn Trust, UK
Review
Phenotypic Spectrum of Subclinical Sarcomere-Related Hypertrophic Cardiomyopathy and Transition to Overt Disease
CC Topriceanu, JC Moon, A Axelsson Raja, G Captur, CY Ho
Circulation: Genomic and Precision Medicine 17 (4), e004580, 2024
Mandates: British Heart Foundation, National Institute for Health Research, UK
Available somewhere: 123
Review
Truncations of titin causing dilated cardiomyopathy
DS Herman, L Lam, MRG Taylor, L Wang, P Teekakirikul, ...
New England Journal of Medicine 366 (7), 619-628, 2012
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, British …
Review
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
I Olivotto, A Oreziak, R Barriales-Villa, TP Abraham, A Masri, ...
The Lancet 396 (10253), 759-769, 2020
Mandates: US National Institutes of Health, US Department of Education
Review
Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy
CY Ho, B López, OR Coelho-Filho, NK Lakdawala, AL Cirino, P Jarolim, ...
New England Journal of Medicine 363 (6), 552-563, 2010
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Genotype and lifetime burden of disease in hypertrophic cardiomyopathy: insights from the Sarcomeric Human Cardiomyopathy Registry (SHaRe)
CY Ho, SM Day, EA Ashley, M Michels, AC Pereira, D Jacoby, AL Cirino, ...
Circulation 138 (14), 1387-1398, 2018
Mandates: US National Institutes of Health, Howard Hughes Medical Institute, American …
Review
Genetic evaluation of cardiomyopathy—a Heart Failure Society of America practice guideline
RE Hershberger, MM Givertz, CY Ho, DP Judge, PF Kantor, KL McBride, ...
Journal of cardiac failure 24 (5), 281-302, 2018
Mandates: US National Institutes of Health
Review
Clinical outcome and phenotypic expression in LAMP2 cardiomyopathy
BJ Maron, WC Roberts, M Arad, TS Haas, P Spirito, GB Wright, ...
Jama 301 (12), 1253-1259, 2009
Mandates: US National Institutes of Health, Howard Hughes Medical Institute
Review
Clinical features and outcome of hypertrophic cardiomyopathy associated with triple sarcomere protein gene mutations
F Girolami, CY Ho, C Semsarian, M Baldi, ML Will, K Baldini, F Torricelli, ...
Journal of the American College of Cardiology 55 (14), 1444-1453, 2010
Mandates: US National Institutes of Health
Review
Evaluation of mavacamten in symptomatic patients with nonobstructive hypertrophic cardiomyopathy
CY Ho, ME Mealiffe, RG Bach, M Bhattacharya, L Choudhury, ...
Journal of the American College of Cardiology 75 (21), 2649-2660, 2020
Mandates: US National Institutes of Health
Review
Myosin sequestration regulates sarcomere function, cardiomyocyte energetics, and metabolism, informing the pathogenesis of hypertrophic cardiomyopathy
CN Toepfer, AC Garfinkel, G Venturini, H Wakimoto, G Repetti, L Alamo, ...
Circulation 141 (10), 828-842, 2020
Mandates: US National Science Foundation, US National Institutes of Health, Howard …
Review
Long-term arrhythmic and nonarrhythmic outcomes of lamin A/C mutation carriers
S Kumar, SH Baldinger, E Gandjbakhch, P Maury, JM Sellal, ...
Journal of the American college of cardiology 68 (21), 2299-2307, 2016
Mandates: National Health and Medical Research Council, Australia
Review
T1 measurements identify extracellular volume expansion in hypertrophic cardiomyopathy sarcomere mutation carriers with and without left ventricular hypertrophy
CY Ho, SA Abbasi, TG Neilan, RV Shah, Y Chen, B Heydari, AL Cirino, ...
Circulation: Cardiovascular Imaging 6 (3), 415-422, 2013
Mandates: US National Institutes of Health, Government of Spain
Review
Genetic advances in sarcomeric cardiomyopathies: state of the art
CY Ho, P Charron, P Richard, F Girolami, KY Van Spaendonck-Zwarts, ...
Cardiovascular research 105 (4), 397-408, 2015
Mandates: US National Institutes of Health, Government of Italy
Review
Common genetic variants and modifiable risk factors underpin hypertrophic cardiomyopathy susceptibility and expressivity
AR Harper, A Goel, C Grace, KL Thomson, SE Petersen, X Xu, A Waring, ...
Nature genetics 53 (2), 135-142, 2021
Mandates: US National Institutes of Health, British Heart Foundation, Cancer Research …
Review
Distinct subgroups in hypertrophic cardiomyopathy in the NHLBI HCM registry
S Neubauer, P Kolm, CY Ho, RY Kwong, MY Desai, SF Dolman, ...
Journal of the American College of Cardiology 74 (19), 2333-2345, 2019
Mandates: US National Institutes of Health, British Heart Foundation, UK Medical …
Publication and funding information is determined automatically by a computer program